CN110755590B - 一种保心胶囊及其制备方法 - Google Patents
一种保心胶囊及其制备方法 Download PDFInfo
- Publication number
- CN110755590B CN110755590B CN201911161038.6A CN201911161038A CN110755590B CN 110755590 B CN110755590 B CN 110755590B CN 201911161038 A CN201911161038 A CN 201911161038A CN 110755590 B CN110755590 B CN 110755590B
- Authority
- CN
- China
- Prior art keywords
- parts
- heart
- capsule
- volatile oil
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 40
- 239000004863 Frankincense Substances 0.000 claims abstract description 26
- 241000758794 Asarum Species 0.000 claims abstract description 20
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 20
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 20
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 20
- 235000017008 Dioscorea nipponica Nutrition 0.000 claims abstract description 20
- 241000908494 Dioscorea nipponica Species 0.000 claims abstract description 20
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 20
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 20
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 20
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 20
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 20
- 235000008397 ginger Nutrition 0.000 claims abstract description 20
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 19
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 19
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 18
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 18
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 18
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 18
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 18
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 18
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 18
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 18
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 18
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 18
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 18
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 18
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 18
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 18
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 5
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000000341 volatile oil Substances 0.000 claims description 25
- 239000003088 amphibian venom Substances 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 14
- 238000002791 soaking Methods 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- 239000008158 vegetable oil Substances 0.000 claims description 10
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000014101 wine Nutrition 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 230000001376 precipitating effect Effects 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000000703 high-speed centrifugation Methods 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 238000001256 steam distillation Methods 0.000 claims description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 2
- 235000020097 white wine Nutrition 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 33
- 208000029078 coronary artery disease Diseases 0.000 abstract description 18
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 17
- 206010003119 arrhythmia Diseases 0.000 abstract description 15
- 230000006793 arrhythmia Effects 0.000 abstract description 15
- 229940079593 drug Drugs 0.000 abstract description 12
- 241000721047 Danaus plexippus Species 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 241000234314 Zingiber Species 0.000 description 15
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 244000132619 red sage Species 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000010135 fructus aurantii immaturus Substances 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- WZRCQWQRFZITDX-UHFFFAOYSA-N (RS)-norcoclaurine Chemical compound C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-UHFFFAOYSA-N 0.000 description 1
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241001478385 Eupatorium japonicum Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- WZRCQWQRFZITDX-AWEZNQCLSA-N Norcoclaurine Natural products C1=CC(O)=CC=C1C[C@H]1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-AWEZNQCLSA-N 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000193241 Solanum dulcamara Species 0.000 description 1
- 235000010307 Solanum dulcamara var. dulcamara Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000345 effect on arrhythmia Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种保心胶囊及其制备方法,采用如下重量份的原料制成,穿龙薯蓣4‑8份、三七3‑6份、黄精2‑4份、蟾酥0.1‑0.2份、莲子2‑4份、金英子1‑2份、山楂3‑6份、丹参5‑10份、红枣3‑6份、枸杞2‑4份、生姜3‑6份、乳香1‑3份、没药1‑3份,细辛0.5‑1份、泽兰3‑6份。本发明诸药合用,采用君臣佐使的配伍原则,多种药用组分起协同作用,相辅相成,故治疗心律失常、改善冠心病、心绞痛等的效果显著,本发明药性平和,可长期服用,不会对人体带来副作用。
Description
技术领域
本发明属于医药技术领域,涉及一种保心胶囊及其制备方法。
背景技术
心血管疾病又称为循环系统疾病,泛指一切和心脏血管有关的疾病,也可以包括冠心病、高血压、心律失常等多种病症。而心血管疾病大多数都是由饮食不调,情绪、遗传等因素引起的。而心血管疾病的症状,也就是说冠状病的症状主要包括的是心绞痛和心肌梗塞,比如胸闷、心悸不宁、心慌、气短、心律不齐、胸痛、气紧、晕厥、虚弱、嗳气等不良表现,胸部刺痛、固定不移等,主要是冠心病的心绞痛。
目前,临床治疗方法中,采用西医或者中医进行治疗,西药治疗的优点是见效快,能够实现血管的快速扩张,从而能够短时间内令堵塞的血管畅通起来。但是西药治疗存在的缺点是副作用较大,长期使用会对血管和人体器官带来不同程度的伤害,且只治标不治本。中药治疗副作用小,但目前市场上出现的中药组合物,其治疗效果欠佳,口感差,见效较慢。
发明内容
为了克服现有技术的不足,本发明提供一种保心胶囊及其制备方法,制备方法简单,本申请的保心胶囊口感好,治疗效果较好,见效快。
本发明提供了如下的技术方案:一种保心胶囊,采用如下重量份的原料制成,穿龙薯蓣4-8份、三七3-6份、黄精2-4份、蟾酥0.1-0.2份、莲子2-4份、金英子1-2份、山楂3-6份、丹参5-10份、红枣3-6份、枸杞2-4份、生姜3-6份、乳香1-3份、没药1-3份,细辛0.5-1份、泽兰3-6份。
优选的是,采用如下重量份的原料制成,穿龙薯蓣5-7份、三七3.5-5.5份、黄精2.5-3.5份、蟾酥0.12-0.18份、莲子2.5-3.5份、金英子1.2-1.8份、山楂4-5份、丹参6-8份、红枣3.5-5.5份、枸杞2.5-3.5份、生姜4-5份、乳香1.5-2.5份、没药1.5-2.5份,细辛0.6-0.8份、泽兰4-5份。
上述任一方案中优选的是,采用如下重量份的原料制成,穿龙薯蓣4份、三七3份、黄精2份、蟾酥0.1份、莲子2份、金英子1份、山楂3份、丹参5份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份、泽兰3份.
上述任一方案中优选的是,采用如下重量份的原料制成,穿龙薯蓣6份、三七4份、黄精3份、蟾酥0.5份、莲子3份、金英子1.6份、山楂4份、丹参7份、红枣4份、枸杞3份、生姜4份、乳香2份、没药2份,细辛0.7份、泽兰4份、
上述任一方案中优选的是,采用如下重量份的原料制成,穿龙薯蓣8份、三七6份、黄精4份、蟾酥0.2份、莲子4份、金英子2份、山楂6份、丹参10份、红枣6份、枸杞4份、生姜6份、乳香3份、没药3份,细辛1份、泽兰6份。
本发明还提供了一种上述保心胶囊的制备方法,包括以下步骤 :
a、按照重量配比称取穿龙薯蓣、三七、黄精、莲子、丹参、乳香、没药、细辛混合,加入 5-10 倍 量的水浸泡 1-2 小时,提取 2-5 小时的挥发油,收集挥发油,药液过滤,药渣备用 ;
b、 取剩余山楂、红枣、枸杞、生姜和所述步骤 a 的药渣混合,加55% -90%乙醇,浸泡 0.5-1.5 小时, 提取两次,每次 1.5-2.5 小时,第一次加 5-10 倍量,第二次加 5-10 倍量,合并提取液,过滤 ;将滤液减压浓缩至相对密度为 80℃时 1.10-1.50,醇沉两次,调乙醇浓度至 60% -90%,取上清 液浓缩至相对密度为 80℃时 1.10-1.50,得浸膏;
c、取上述浸膏,加入步骤 a 得到的挥发油及植物油、蟾酥,植物油的添加量占浸膏和挥发油总质量的 1.5-4%,混合,用胶体磨研磨 10 分钟,不断搅拌,冷却至室温,将所述中药组合物装入胶囊壳体中,即得所述保心胶囊。
上述任一方案中优选的是,所述的步骤 a 中挥发油的提取采用超临界萃取法或水蒸气蒸馏法提取。 超临界萃取法或水蒸气蒸馏法提取均是本领域技术人员常用的技术,在此不再赘述。
上述任一方案中优选的是,所述的步骤 b 中提取采用超滤、醇沉、高速离心或大孔树脂方法。超滤、醇沉、高速离心或大孔树脂方法也是本领域技术人员常用的技术,在此不再赘述。
上述任一方案中优选的是,所述的蟾酥为酒蟾酥,蟾酥捣碎,用白酒浸渍,不断搅动至呈稠膏状,干燥,粉碎。
上述任一方案中优选的是,所述的蟾酥和白酒的用量比为1:1.5-3。
上述任一方案中优选的是,所述的蟾酥和白酒的用量比为1:1.5。
上述任一方案中优选的是,所述的蟾酥和白酒的用量比为1:2。
上述任一方案中优选的是,所述的蟾酥和白酒的用量比为1:3。
本发明所使用的原料药以及药用辅料,各项指标均符合2015版《中华人民共和国药典》记载,本发明还提供了上述药物药理活性:
本发明所用药物包括穿龙薯蓣,有明显的止咳、祛痰、平喘作用,对组胺或乙酞胆碱喷雾引起的支气管痉挛均有预防作用,此作用有效成分在极性最强的部分及 甾体皂苷;能够降低兔血胆固醇及血压,延缓心率、增大心肌收缩振 幅、增加尿量、改善冠脉循环,可治疗轻度动脉粥样硬。性味性温,味廿、苦。
三七,有扩张血管的作用,它有溶解血栓,改善微循环,预防和治疗高血脂、高胆固醇血症、冠心病、心绞痛,还有脑血管疾病当中,所以它有个活血的作用,这种活血的作用可以改善,心脑血管的这种缺血性的疾病,同时它在止血过程当中,它还能够化瘀,有止血不留瘀的作用,
黄精能抑菌、抗菌,缓解由皮肤真菌所引发的病症,能加强心肌功能,预防一些心血管系统疾病的发生。 蟾酥,强心、抗炎、抗肿瘤。
莲子,含有多种生物碱,而这些生物碱有着很好的强健心脏的作用,对于心律不齐有很好的缓解作用。
金英子,可以降血脂,减少脂肪在血管内的沉积,有造血、活血、软化动脉血管的作用,用于治疗动脉粥样硬化症等。
山楂能治高血脂、高血压、冠心病并抗癌抗衰老。
丹参有扩张血管与增进冠状动脉流量的作用,可治冠心病、心绞痛、心肌梗塞、心动过速等。
红枣,健脾益气,养阴安神,能够调和药性。
枸杞,性味甘平,中医认为它具有滋补肝肾、益精明目及养血的功效,能够增强人体的免疫力。
生姜,味辛,性微温,归肺、脾、胃经。生姜具有发汗解表、温中止呕、温肺止咳、解鱼蟹毒、解药毒的作用。
乳香,乳香和没药是临床上常用的一组活血化瘀、消肿止痛的对药,是祛瘀止痛类的药物。乳香和没药对内通脏腑气血,能够治疗胸背心痛、胃脘疼痛、痛经、产后淤阻、腹痛;对外外通经络,能够治疗风湿痹症、经脉痉挛、跌打损伤、臃肿疮疡。
细辛,动物实验表明,细辛挥发油对离体蛙心,小剂量时呈兴奋作用。北细辛醇提液对离体兔心有明显的兴奋效果,可使离体豚鼠心脏冠脉流量增加。细辛挥发油对小鼠急性心肌缺血、低压缺氧等均有保护功效。可使狗左室泵血功能和心肌收缩性明显改善。与去甲乌药碱、异丙基肾上腺素基本相似。
泽兰,对心肌缺血具有保护作用,抗凝血。
本申请的保心胶囊具有活血化瘀,行气止痛的功效。用于心绞痛,心律失常,改善冠心病症状等,对心律失常有较好的调整,可改善微循环,并增强心肌的收缩力。
本发明组方以丹参和穿龙薯蓣为君药,活血化瘀,散瘀止痛,穿龙薯蓣能够增大心肌收缩振幅、改善冠脉循环,乳香、没药、活血止痛,诸药合用,可明显改善心绞痛、心律失常、冠心病、胸痛、胸闷、心悸气短等症状。
本发明诸药合用,采用君臣佐使的配伍原则,多种药用组分起协同作用,相辅相成,故治疗心律失常、改善冠心病、心绞痛等的效果显著。本发明的有益效果体现在:本发明药性平和,可长期服用,不会对人体带来副作用。
具体实施方式
为了进一步了解本发明的技术特征,下面结合具体实施例对本发明进行详细地阐述。实施例只对本发明具有示例性的作用,而不具有任何限制性的作用,本领域的技术人员在本发明的基础上做出的任何非实质性7的修改,都应属于本发明的保护范围。
实施例 1: 一种保心胶囊,采用以下组分制备而成:穿龙薯蓣4份、三七3份、黄精2份、蟾酥0.1份、莲子2份、金英子1份、山楂3份、丹参5份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份、泽兰3份。
本实施例的治疗颈肩腰腿痛的外用膏药的制备方法,包括以下各步骤:
按照重量配比称取穿龙薯蓣、三七、黄精、莲子、丹参、乳香、没药、细辛混合,加入5 倍 量的水浸泡 1 小时,提取 2小时的挥发油,收集挥发油,挥发油的提取采用超临界萃取法或水蒸气蒸馏法提取,药液过滤,药渣备用 ; b、取剩余山楂、红枣、枸杞、生姜和所述步骤 a 的药渣混合,加55% 乙醇,浸泡 0.5 小时, 采用超滤、醇沉、高速离心或大孔树脂方法提取两次,每次 1.5小时,第一次加 5 倍量,第二次加 5倍量,合并提取液,过滤 ;将滤液减压浓缩至相对密度为 80℃时 1.10,醇沉两次,调乙醇浓度至 60% ,取上清 液浓缩至相对密度为 80℃时 1.10,得浸膏 ; c、取上述浸膏,加入步骤 a 得到的挥发油及植物油、蟾酥,植物油的添加量占浸膏和挥发油总质量的 1.5%,混合,用胶体磨研磨 10 分钟,不断搅拌,冷却至室温,将所述中药组合物装入胶囊壳体中,即得所述保心胶囊。
本申请的蟾酥为酒蟾酥,蟾酥捣碎,用白酒浸渍,不断搅动至呈稠膏状,干燥,粉碎。蟾酥和白酒的用量比为1:1.5。
实施例 2:一种保心胶囊,采用以下组分制备而成:穿龙薯蓣6份、三七4份、黄精3份、蟾酥0.5份、莲子3份、金英子1.6份、山楂4份、丹参7份、红枣4份、枸杞3份、生姜4份、乳香2份、没药2份,细辛0.7份、泽兰4份。
本实施例的保心胶囊制备方法,和实施例1不同的是,包括以下各步骤:
按照重量配比称取穿龙薯蓣、三七、黄精、莲子、丹参、乳香、没药、细辛混合,加入7 倍 量的水浸泡 1.5 小时,提取 3 小时的挥发油,收集挥发油,药液过滤,药渣备用 ;b、取剩余山楂、红枣、枸杞、生姜和所述步骤 a 的药渣混合,加65%乙醇,浸泡 1 小时, 提取两次,每次 2 小时,第一次加8倍量,第二次加8倍量,合并提取液,过滤 ;将滤液减压浓缩至相对密度为 80℃时 1.30,醇沉两次,调乙醇浓度至 75%,取上清 液浓缩至相对密度为 80℃时 1.30,得浸膏 ; c、取上述浸膏,加入步骤 a 得到的挥发油及植物油、蟾酥,植物油的添加量占浸膏和挥发油总质量的 3%,混合,用胶体磨研磨 10 分钟,不断搅拌,冷却至室温,将所述中药组合物装入胶囊壳体中,即得所述保心胶囊。
蟾酥和白酒的用量比为1:2。
实施例 3:一种治疗颈肩腰腿痛的外用膏药,采用以下组分制备而成:穿龙薯蓣7份、三七5.5份、黄精3.5份、蟾酥0.18份、莲子3.5份、金英子1.8份、山楂5份、丹参8份、红枣5.5份、枸杞3.5份、生姜5份、乳香2.5份、没药2.5份,细辛0.8份、泽兰5份。
本实施例的治疗颈肩腰腿痛的外用膏药的制备方法,和实施例1不同的是,包括以下各步骤:
按照重量配比称取穿龙薯蓣、三七、黄精、莲子、丹参、乳香、没药、细辛混合,加入10 倍 量的水浸泡 2 小时,提取 5 小时的挥发油,收集挥发油,药液过滤,药渣备用 ; b、取剩余山楂、红枣、枸杞、生姜和所述步骤 a 的药渣混合,加90%乙醇,浸泡 1.5 小时, 提取两次,每次 2.5 小时,第一次加 10 倍量,第二次加 10 倍量,合并提取液,过滤 ;将滤液减压浓缩至相对密度为 80℃时 1.50,醇沉两次,调乙醇浓度至 90%,取上清液浓缩至相对密度为 80℃时 1.50,得浸膏 ; c、取上述浸膏,加入步骤 a 得到的挥发油及植物油、蟾酥,植物油的添加量占浸膏和挥发油总质量的 4%,混合,用胶体磨研磨 10 分钟,不断搅拌,冷却至室温,将所述中药组合物装入胶囊壳体中,即得所述保心胶囊。
本实施例的蟾酥和白酒的用量比为1:3。
实施例 4:一种保心胶囊,和实施例2不同的是,采用以下组分制备而成:
穿龙薯蓣8份、三七6份、黄精4份、蟾酥0.2份、莲子4份、金英子2份、山楂6份、丹参10份、红枣6份、枸杞4份、生姜6份、乳香3份、没药3份,细辛1份、泽兰6份。
实施例 5:一种保心胶囊,和实施例2不同的是,采用以下重量份的原料制成三七3份、黄精2份、蟾酥0.1份、莲子2份、金英子1份、山楂3份、丹参5份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份、泽兰3份。
实施例6:一种保心胶囊,和实施例2不同的是,采用以下重量份的原料制成:穿龙薯蓣4份、三七3份、黄精2份、蟾酥0.1份、莲子2份、金英子1份、山楂3份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份、泽兰3份。
实施例7:一种保心胶囊,和实施例2不同的是,采用以下重量份的原料制成:穿龙薯蓣4份、三七3份、黄精2份、、莲子2份、金英子1份、山楂3份、丹参5份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份、泽兰3份。
实施例8:一种保心胶囊,和实施例2不同的是,采用以下重量份的原料制成:穿龙薯蓣4份、三七3份、黄精2份、蟾酥0.1份、莲子2份、金英子1份、山楂3份、丹参5份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份。
实施例9:一种保心胶囊,和实施例2不同的是,采用以下重量份的原料制成:穿龙薯蓣4份、三七3份、黄精2份、蟾酥0.1份、莲子2份、、山楂3份、丹参5份、红枣3份、枸杞2份、生姜3份、乳香1份、没药1份,细辛0.5份、泽兰3份。
临床治疗效果
自2016年1月至2019年5月,系统观察了120例患者,其中男78例,女42例,年龄42岁- 68岁,平均年龄55岁,最短病程0.5月,最长病程5年,平均病程1.5年。
采取随机数字表法将所有患者随机双盲分为6组,实施例1组20例,实施例2组20例,实施例3组20例,实施例4组20例,实施例5组20例,对照组20例。
六组患者临床资料进行可比性分析,六组病例在年龄、病程等方面比较差异均无统计学意义(P>0.05),具有可比性。
给药方案,根据自愿原则,选择自愿接受试药的上述确诊患者共计120例,其中20例用于对照组的药物为现市场销售的保心宁片,其余100例分成五组分别使用本发明实施例1-实施例5的保心胶囊,结果见表1至3。
疗效主要判定依据如下。
1)心绞痛效果:
优:心绞痛很快缓解,良:心绞痛有所缓解,中:心绞痛稍有缓解,差:用药一个疗程后,心绞痛基本没有缓解。
2)心律失常效果:
优:心律失常很快缓解,良:心律失常有所缓解,中:心律失常稍有缓解,差:用药一个疗程后,心律失常基本没有缓解。
3)改善冠心病症状效果:
优:冠心病症状有很大程度改善,良:冠心病症状有所改善,中:冠心病症状稍有改善,差:用药一个疗程后,冠心病症状基本没有改善。
服用方法:早晚各一次,每次2粒,温水送服。10天为一个疗程。三个疗程之后统计治疗结果。
心绞痛治疗效果如下表1所示:
表1心绞痛治疗效果数据
组别 | 优 | 良 | 中 | 差 |
实施例1 | 10 | 5 | 3 | 2 |
实施例2 | 15 | 2 | 1 | 2 |
实施例3 | 13 | 3 | 2 | 2 |
实施例4 | 12 | 3 | 2 | 3 |
实施例5 | 4 | 4 | 2 | 10 |
对照组 | 9 | 6 | 2 | 3 |
心律失常治疗效果如下表2:
表2心律失常治疗效果数据
组别 | 优 | 良 | 中 | 差 |
实施例1 | 9 | 4 | 5 | 2 |
实施例2 | 14 | 3 | 2 | 1 |
实施例3 | 12 | 4 | 2 | 2 |
实施例4 | 11 | 5 | 3 | 1 |
实施例5 | 5 | 4 | 3 | 8 |
对照组 | 10 | 5 | 3 | 2 |
冠心病治疗效果如下表3:
表3 冠心病治疗效果数据
组别 | 优 | 良 | 中 | 差 |
实施例1 | 10 | 4 | 3 | 3 |
实施例2 | 15 | 2 | 2 | 1 |
实施例3 | 13 | 1 | 3 | 3 |
实施例4 | 12 | 3 | 2 | 3 |
实施例5 | 6 | 3 | 2 | 9 |
对照组 | 12 | 3 | 2 | 3 |
表1-表3的结果表明:本发明实施例1-5制备的保心胶囊用于心绞痛、心律失常和改善冠心病症状等,效果优于对照组,其中实施例2效果最为显著。
当然本申请同时还进行了多组其他临床试验,如实施例6-实施例9等,通过关键药物组分的缺失进行治疗效果验证,最后发现治疗效果相差很大,这也进一步证明了本申请的各个药物采用君臣佐使的配伍原则,各个组份相辅相成,相互辅佐,进一步保证治疗效果,在此不再一一列举。
Claims (4)
1.一种保心胶囊,其特征在于,采用如下重量份的原料制成,穿龙薯蓣5-7份、三七3.5-5.5份、黄精2.5-3.5份、蟾酥0.12-0.18份、莲子2.5-3.5份、金英子1.2-1.8份、山楂4-5份、丹参6-8份、红枣3.5-5.5份、枸杞2.5-3.5份、生姜4-5份、乳香1.5-2.5份、没药1.5-2.5份,细辛0.6-0.8份、泽兰4-5份,所述的保心胶囊的制备方法:包括以下步骤:a、按照重量配比称取穿龙薯蓣、三七、黄精、莲子、丹参、乳香、没药、细辛混合,加入5-10倍量的水浸泡1-2小时,提取2-5小时的挥发油,收集挥发油,药液过滤,药渣备用;b、取剩余山楂、红枣、枸杞、生姜和所述步骤a的药渣混合,加55%-90%乙醇,浸泡0.5-1.5小时,提取两次,每次1.5-2.5小时,第一次加5-10倍量,第二次加5-10倍量,合并提取液,过滤;将滤液减压浓缩至相对密度为80℃时1.10-1.50,醇沉两次,调乙醇浓度至60%-90%,取上清液浓缩至相对密度为80℃时1.10-1.50,得浸膏;c、取上述浸膏,加入步骤a得到的挥发油及植物油、蟾酥,植物油的添加量占浸膏和挥发油总质量的1.5-4%,所述的蟾酥为酒蟾酥,蟾酥捣碎,用白酒浸渍,不断搅动至呈稠膏状,干燥,粉碎,所述的蟾酥和白酒的用量比为1:1.5-3,混合,用胶体磨研磨10分钟,不断搅拌,冷却至室温,将所述中药组合物装入胶囊壳体中,即得所述保心胶囊。
2.根据权利要求1所述的保心胶囊,其特征在于:采用如下重量份的原料制成,穿龙薯蓣6份、三七4份、黄精3份、蟾酥0.5份、莲子3份、金英子1.6份、山楂4份、丹参7份、红枣4份、枸杞3份、生姜4份、乳香2份、没药2份,细辛0.7份、泽兰4份。
3.根据权利要求1所述的一种保心胶囊,其特征在于:所述的步骤a中挥发油的提取采用超临界萃取法或水蒸气蒸馏法提取。
4.根据权利要求1所述的一种保心胶囊,其特征在于:所述的步骤b中提取采用超滤、醇沉、高速离心或大孔树脂方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911161038.6A CN110755590B (zh) | 2019-11-24 | 2019-11-24 | 一种保心胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911161038.6A CN110755590B (zh) | 2019-11-24 | 2019-11-24 | 一种保心胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110755590A CN110755590A (zh) | 2020-02-07 |
CN110755590B true CN110755590B (zh) | 2021-11-05 |
Family
ID=69339108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911161038.6A Active CN110755590B (zh) | 2019-11-24 | 2019-11-24 | 一种保心胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110755590B (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096217A (zh) * | 1994-01-29 | 1994-12-14 | 薛彦 | 一种预防心脑血管疾病的中药饮料 |
CN1120017C (zh) * | 1999-04-05 | 2003-09-03 | 河南省洛阳正骨研究所 | 一种治疗软组织损伤的喷雾剂及制备方法 |
CN102526423A (zh) * | 2012-01-06 | 2012-07-04 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种治疗缺血性心脏病的药物组合 |
CN107375882A (zh) * | 2017-08-08 | 2017-11-24 | 郑州韩都药业集团有限公司 | 一种保心宁颗粒的制备方法 |
CN107595811A (zh) * | 2017-10-10 | 2018-01-19 | 陕西中医药大学 | 一种治疗冠心病的缓释胶囊及其制备方法 |
CN110179949A (zh) * | 2019-06-24 | 2019-08-30 | 嵊州市王氏医疗器械有限公司 | 一种治疗颈肩腰腿痛的外用膏药及其制备方法和应用 |
-
2019
- 2019-11-24 CN CN201911161038.6A patent/CN110755590B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110755590A (zh) | 2020-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017005220A1 (zh) | 用于治疗心律失常的中药组合物及其制备方法 | |
CN104013756B (zh) | 一种防治腹泻的中药组合物及其用途 | |
CN103933487A (zh) | 一种治疗抑郁症的复方中药 | |
CN111437378B (zh) | 一种用于防治慢性心力衰竭的中药组合物、药物及其制备方法 | |
CN116370556B (zh) | 一种活血祛瘀、益气安神的中药组合物及其制备方法 | |
CN101172155A (zh) | 生脉温胆汤新剂型及其生产方法 | |
CN110876772A (zh) | 一种具有保肝护肝功能的中药制剂的制备方法及应用 | |
CN110755590B (zh) | 一种保心胶囊及其制备方法 | |
CN115252753A (zh) | 治疗失眠的中药组合物及其应用 | |
CN113730514A (zh) | 助于提高免疫力的配制酒组合物及其制备方法和使用方法 | |
CN109331107B (zh) | 一种防治宠物病毒性心肌炎的中药组合物、口服液及其制备方法 | |
CN117204560A (zh) | 一种抗尿酸功能性食品 | |
CN105902897A (zh) | 一种治疗胰腺癌的药物制剂及其用途 | |
CN111743066A (zh) | 一种药食同源中药组合物及其应用 | |
CN110882347A (zh) | 一种治疗心血管疾病的中药组合物 | |
CN104524359B (zh) | 一种中药组合物、其制备方法及应用 | |
CN108079113A (zh) | 一种治疗产后血虚的药物组合物及其制备方法 | |
CN102000303B (zh) | 一种抑制肿瘤的中药复方制剂 | |
CN109908294B (zh) | 一种用于治疗支气管扩张症稳定期的药物组合物及其制备方法和用途 | |
CN102772665B (zh) | 一种治疗阴虚内热型病毒性心肌炎的中药制剂及其制备方法 | |
CN106421028A (zh) | 一种抗运动性疲劳的中药组合物及其制备方法 | |
CN114470094A (zh) | 一种促进骨髓间充质干细胞抗肝纤维化的中药组合物及其制备方法 | |
CN105267694B (zh) | 一种调理冠心病的人参保健茶 | |
CN104906265A (zh) | 治疗冠心病的中药组合物 | |
CN105343688A (zh) | 一种治疗心肌梗塞的药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |